Will Natco and Dr. Reddy's bet on weight-loss drug Ozempic's copy pay off?
In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.
Why Novo Nordisk Stock Keeps Going Down
Novo Nordisk (NYSE: NVO) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, ...